OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
002971$41.2159

Hubei Heyuan Gas Co Ltd

Commodity ChemicalsVerified

The company's capital structure is highly leveraged, with a debt-to-equity ratio of 2.51, indicating significant reliance on long-term debt to fund operations. Liquidity is constrained, as evidenced by a current ratio of 0.3, and free cash flow is negative at -455.5 million CNY, driven by capital expenditures of -603.5 million CNY. The price-to-book ratio of 5.49 suggests the market is valuing the company at a premium to its book value, but the price-to-earnings ratio of 144.64 indicates a high multiple relative to earnings. Profitability metrics are weak compared to industry norms. Return on equity (ROE) is 3.8%, and return on assets (ROA) is 0.95%, both below the typical thresholds for chemical companies, which often require ROE above 10% and ROA above 5% to be considered competitive. Gross profit of 314.2 million CNY and operating income of 75.1 million CNY suggest limited margin expansion potential in the near term. Geographic and segment exposure is concentrated in China, with no disclosed international operations or diversified product lines. The company's revenue is entirely derived from the domestic market, and it operates a single business segment focused on industrial gases. This concentration increases vulnerability to local economic and regulatory shifts. Growth trajectory is uncertain. Revenue for the latest period was 1.66 billion CNY, but there is no indication of year-over-year growth in the provided data. Analysts have assigned a mean recommendation of 2.00 (Buy), but only one analyst has issued a Buy rating, with no Strong Buy or Sell ratings, suggesting a cautious outlook. The company's capital expenditures are outpacing operating cash flow, which may hinder future growth unless external financing is secured. Risk factors include high leverage and weak liquidity. The company has negative net cash after subtracting total debt, and its liquidity risk is rated as medium. Dilution risk is low, but the absence of a tangible growth plan and weak profitability metrics could pressure the company to issue additional shares in the future. Recent filings and transcripts do not indicate any material events that would alter the company's risk profile in the near term. The company's recent financial performance and capital structure suggest a need for strategic repositioning. With a market cap of 8.73 billion CNY and a high price-to-earnings ratio, the stock is trading at a premium despite weak earnings and cash flow. This valuation may not be sustainable unless the company can demonstrate meaningful improvements in profitability and capital efficiency.

30-day price · 002971(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyHubei Heyuan Gas Co Ltd
Ticker002971.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Hubei Heyuan Gas Co Ltd produces and distributes industrial gases, primarily serving the chemical and manufacturing sectors in China.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 92% confidence.

The company's capital structure is highly leveraged, with a debt-to-equity ratio of 2.51, indicating significant reliance on long-term debt to fund operations. Liquidity is constrained, as evidenced by a current ratio of 0.3, and free cash flow is negative at -455.5 million CNY, driven by capital expenditures of -603.5 million CNY. The price-to-book ratio of 5.49 suggests the market is valuing the company at a premium to its book value, but the price-to-earnings ratio of 144.64 indicates a high multiple relative to earnings. Profitability metrics are weak compared to industry norms. Return on equity (ROE) is 3.8%, and return on assets (ROA) is 0.95%, both below the typical thresholds for chemical companies, which often require ROE above 10% and ROA above 5% to be considered competitive. Gross profit of 314.2 million CNY and operating income of 75.1 million CNY suggest limited margin expansion potential in the near term. Geographic and segment exposure is concentrated in China, with no disclosed international operations or diversified product lines. The company's revenue is entirely derived from the domestic market, and it operates a single business segment focused on industrial gases. This concentration increases vulnerability to local economic and regulatory shifts. Growth trajectory is uncertain. Revenue for the latest period was 1.66 billion CNY, but there is no indication of year-over-year growth in the provided data. Analysts have assigned a mean recommendation of 2.00 (Buy), but only one analyst has issued a Buy rating, with no Strong Buy or Sell ratings, suggesting a cautious outlook. The company's capital expenditures are outpacing operating cash flow, which may hinder future growth unless external financing is secured. Risk factors include high leverage and weak liquidity. The company has negative net cash after subtracting total debt, and its liquidity risk is rated as medium. Dilution risk is low, but the absence of a tangible growth plan and weak profitability metrics could pressure the company to issue additional shares in the future. Recent filings and transcripts do not indicate any material events that would alter the company's risk profile in the near term. The company's recent financial performance and capital structure suggest a need for strategic repositioning. With a market cap of 8.73 billion CNY and a high price-to-earnings ratio, the stock is trading at a premium despite weak earnings and cash flow. This valuation may not be sustainable unless the company can demonstrate meaningful improvements in profitability and capital efficiency.
Key takeaways
  • The company is highly leveraged with a debt-to-equity ratio of 2.51 and weak liquidity.
  • Profitability metrics (ROE 3.8%, ROA 0.95%) are below industry norms for chemical companies.
  • Revenue is entirely concentrated in China, with no international diversification.
  • Analysts have issued a cautious outlook, with only one Buy rating and no Strong Buy or Sell ratings.
  • Free cash flow is negative, and capital expenditures are outpacing operating cash flow.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.66B
Gross profit$314.2M
Operating income$75.1M
Net income$60.3M
R&D
SG&A
D&A
SBC
Operating cash flow$227.8M
CapEx-$603.5M
Free cash flow-$455.5M
Total assets$6.36B
Total liabilities$4.77B
Total equity$1.59B
Cash & equivalents
Long-term debt$3.99B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$1.66B$75.1M$60.3M-$455.5M
FY-1$1.53B$72.5M$73.2M-$968.2M
FY-2$1.65B$98.4M$83.8M-$288.0M
FY-3$1.32B$92.6M$74.5M-$483.7M
FY-4$991.8M$95.5M$90.2M-$243.2M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$6.36B$1.59B
FY-1$5.72B$1.57B$32.5k
FY-2$4.07B$1.29B
FY-3$2.94B$1.20B
FY-4$2.33B$1.14B
PeriodOCFCapExFCFSBC
FY0$227.8M-$603.5M-$455.5M
FY-1$165.1M-$1.12B-$968.2M
FY-2$20.9M-$456.5M-$288.0M
FY-3$42.5M-$605.7M-$483.7M
FY-4$51.5M-$344.7M-$243.2M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$392.0M$20.2M$18.0M
FQ-1$432.0M$7.8M$2.6M
FQ-2$426.4M$9.3M$8.5M
FQ-3$451.1M$30.7M$24.0M
FQ-4$354.6M$27.7M$25.2M
FQ-5$340.6M$5.1M$14.4M
FQ-6$420.4M$18.8M$15.1M
FQ-7$414.9M$14.4M$13.6M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$6.73B$1.81B$241.9M
FQ-1$6.36B$1.59B$83.6k
FQ-2$5.88B$1.60B$183.2M
FQ-3$6.13B$1.58B$92.8k
FQ-4$5.92B$1.58B$372.1M
FQ-5$5.72B$1.57B$32.5k
FQ-6$4.96B$1.33B$212.6M
FQ-7$4.94B$1.32B$1.0M
PeriodOCFCapExFCFSBC
FQ0$4.8M-$141.8M
FQ-1$227.8M-$603.5M
FQ-2$199.9M-$341.6M
FQ-3$45.5M-$200.7M
FQ-4$5.7M-$83.2M
FQ-5$165.1M-$1.12B
FQ-6$219.8M-$673.1M
FQ-7$11.0M-$545.2M
Valuation
Market price$41.21
Market cap$8.73B
Enterprise value$12.72B
P/E144.6
Reported non-GAAP P/E
EV/Revenue7.6
EV/Op income169.2
EV/OCF55.8
P/B5.5
P/Tangible book5.5
Tangible book$1.59B
Net cash-$3.99B
Current ratio0.3
Debt/Equity2.5
ROA0.9%
ROE3.8%
Cash conversion3.8%
CapEx/Revenue-36.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002971Activity
Op margin4.5%0.4% medp25 -8.0% · p75 16.0%above median
Net margin3.6%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin18.9%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-36.3%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity251.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.52 CNY
Last actual EPS0.29 CNY
Mean revenue estimate1,720,000,000 CNY
Last actual revenue1,664,034,900 CNY
Mean EBIT estimate133,000,000 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-18 00:48 UTCJob: 635f3e3f